Un-Mainstreaming Human Enhancement
By Charles T. Rubin,
The New Atlantis
| 11. 07. 2012
America’s Grey Lady, the
New York Times, has long been willing to take transhumanist topics seriously, perhaps in some hope that she too will be somehow rejuvenated. Indeed,
a recent piece by David Ewing Duncan on human enhancement has something of the aura of a second childhood about it, with its relatively breathless and uncritical account of the various promising technologies of enhancement in the works. There follows the stock paragraph noting with remarkable brevity the safety, distributional, political and “what it means to be human” issues these developments might create, before Duncan really gets to the core of the matter: “Still, the enhancements are coming, and they will be hard to resist. The real issue is what we do with them once they become irresistible.”
Here at Futurisms, we were not unaware that human enhancements may be hard to resist. Speaking only for myself, however, I can add that there are all kinds of things I find hard to resist. It was hard to resist the desire to stay in bed this morning, hard to resist the desire...
Related Articles
Sir Francis Galton, 1890s, by Eveleen Myers (née Tennant)
npg.org
Public Domain via Wikipedia
As has been discussed in recent issues of Biopolitical Times (1, 2), there are, increasingly, companies that claim to be selling parents better babies by selecting the “best” embryos. These services don’t come cheap – think $50,000, or even more, for embryo testing, plus perhaps as much again for IVF and concomitant services. To most of us, that is extremely expensive...
By Aaron Ginn, The Washington Post | 09.12.2025
Earlier this year, I had dinner in D.C. with Jensen Huang, the president and chief executive of Nvidia. At one point, he said something that struck me: “Why is everyone here so negative?”
He wasn’t referring to the economy...
By Kevin Roose, The New York Times | 09.12.2025
The first time I met Eliezer Yudkowsky, he said there was a 99.5 percent chance that A.I. was going to kill me.
I didn’t take it personally. Mr. Yudkowsky, 46, is the founder of the Machine Intelligence Research Institute, a...
By Roni Caryn Rabin, The New York Times | 08.25.2025
Scientists have dreamed for centuries about using animal organs to treat ailing humans. In recent years, those efforts have begun to bear fruit: Researchers have begun transplanting the hearts and kidneys of genetically modified pigs into patients, with varying degrees...